Loading...
Vaccine
India Pharmaceutical Trade Intelligence
Who Supplies Vaccine to India from INDONESIA
India's vaccine imports from INDONESIA total $954.8M across 576 shipments from 5 foreign suppliers. PT VAKSINDO SATWA NUSANTARA leads with $930.2M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include VAKSINDO ANIMAL HEALTH PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for vaccine — a diversified sourcing base with multiple active suppliers from INDONESIA.
Top foreign suppliers (INDONESIA) — Ranked by import value
PT VAKSINDO SATWA NUSANTARA is the leading Vaccine supplier from INDONESIA to India, with import value of $930.2M across 545 shipments. The top 5 suppliers — PT VAKSINDO SATWA NUSANTARA, BIONET-ASIA CO., LTD, BIONET-ASIA CO LIMITED, BIONET-ASIA CO. LIMITED, PT. VAKSINDO SATWA NUSANTARA — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (INDONESIA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PT VAKSINDO SATWA NUSANTARA | $930.2M | 545 | 97.4% |
| 2 | BIONET-ASIA CO., LTD | $16.9M | 20 | 1.8% |
| 3 | BIONET-ASIA CO LIMITED | $6.1M | 6 | 0.6% |
| 4 | BIONET-ASIA CO. LIMITED | $1.7M | 2 | 0.2% |
| 5 | PT. VAKSINDO SATWA NUSANTARA | $282 | 3 | 0.0% |
Showing top 5 of 5 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from INDONESIA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | VAKSINDO ANIMAL HEALTH PRIVATE LIMITED | $930.2M | 548 | 97.4% |
| 2 | HAFFKINE BIO PHARMACEUTICAL CORPORATION LIMITED | $24.7M | 28 | 2.6% |
Import Statistics
- Import Value
- $954.8M
- Shipments
- 576
- Foreign Suppliers
- 5
- Indian Buyers
- 2
- Avg. Shipment
- $1.7M
Other Vaccine Import Origins
Related Analysis
Frequently Asked Questions — Vaccine Imports from INDONESIA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Vaccine suppliers from INDONESIA to India?
The top Vaccine suppliers from INDONESIA to India include PT VAKSINDO SATWA NUSANTARA, BIONET-ASIA CO., LTD, BIONET-ASIA CO LIMITED. The leading supplier is PT VAKSINDO SATWA NUSANTARA with import value of $930.2M USD across 545 shipments. India imported Vaccine worth $954.8M USD from INDONESIA in total across 576 shipments.
QHow much Vaccine does India import from INDONESIA?
India imported Vaccine worth $954.8M USD from INDONESIA across 576 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Vaccine from INDONESIA?
The main Indian buyers of Vaccine sourced from INDONESIA include VAKSINDO ANIMAL HEALTH PRIVATE LIMITED, HAFFKINE BIO PHARMACEUTICAL CORPORATION LIMITED. The largest buyer is VAKSINDO ANIMAL HEALTH PRIVATE LIMITED with $930.2M in imports across 548 shipments.
QWhat is the total value of Vaccine imports from INDONESIA to India?
The total value of Vaccine imports from INDONESIA to India is $954.8M USD, across 576 shipments and 5 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: INDONESIA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Vaccine.
- 2.Supplier/Buyer Matching: 5 foreign suppliers from INDONESIA and 2 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $954.8M aggregated from 576 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
576 Verified Shipments
5 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists